{"product_id":"cst-2690s","title":"CST,  2690S, IKK epsilon Antibody","description":"Polyclonal Antibody for studying IKK-epsilon. Validated for Western Blotting. Available in 2 sizes. Highly specific and rigorously validated in-house, IKK epsilon Antibody (CST #2690) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA and 50% glycerol. Store at -20°C. Do not aliquot the antibody.\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nIKK epsilon Antibody detects endogenous levels of total IKKÎµ protein. This antibody does not cross-react with other IKKs or with TBK1\/NAK.\nSpecies Reactivity: Human, Mouse, Rat\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nPolyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to a region near the carboxyl terminus of IKKÎµ protein. Antibodies are purified by peptide affinity chromatography.\n\u003cb\u003eBackground\u003c\/b\u003e\nThe NF-ÎºB\/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IÎºB proteins (1-3). Most agents that activate NF-ÎºB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IÎºB (3-7). The key regulatory step in this pathway involves activation of a high molecular weight IÎºB kinase (IKK) complex whose catalysis is generally carried out by three tightly associated IKK subunits. IKKÎ± and IKKÎ² serve as the catalytic subunits of the kinase and IKKÎ³ serves as the regulatory subunit (8,9). Activation of IKK depends upon phosphorylation at Ser177 and Ser181 in the activation loop of IKKÎ² (Ser176 and Ser180 in IKKÎ±), which causes conformational changes, resulting in kinase activation (10-13). Recently, two homologs of IKKÎ± and IKKÎ² have been described, called IKKÎµ (also known as IKK-i) and TBK1 (also known as T2K or NAK). Activation of either of these kinases results in NF-ÎºB activation. IKKÎµ contains the kinase domain in its amino terminus, which shares 30% identity to that of IKKÎ± or IKKÎ². IKKÎµ is expressed mainly in immune cells and may play a special role in the immune response (14-18).\n\u003cb\u003eAlternate Names\u003c\/b\u003e\nI-kappa-B kinase epsilon; IKBKE; IKK-E; IKK-epsilon; IKK-i; IKK-related kinase epsilon; IKKE; IKKI; Inducible I kappa-B kinase; inducible IkappaB kinase; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; inhibitor of nuclear factor kappa B kinase subunit epsilon; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; KIAA0151; MGC125294; MGC125295; MGC125297\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H M R\nSENSITIVITY: Endogenous\nMW (kDa): 80\nSOURCE: Rabbit","brand":"CST","offers":[{"title":"Default Title","offer_id":46797941866665,"sku":"2690S","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-2690s","provider":"Iright","version":"1.0","type":"link"}